Side effects seen in every 1 of 7 Sputnik V volunteers in Russia
MOSCOW, RUSSIA - SEPTEMBER 9, 2020: A medical worker gives a volunteer a trial vaccine against COVID-19 at Moscow's N62 Outpatient Clinic in a post-registration phase of testing. Sergei Bobylev/TASS
Russia was the first to announce that it had tested and approved the vaccine they labelled Sputnik V against the global pandemic currently afflicting millions worldwide. Recent reports that have surfaced, however, have claimed that 1 in every 7 of the people who volunteered for the vaccine trials have developed side effects. 14% of the individuals have remarked that they are suffering through fever, muscle aches and weakness, according to the Russian News Agency, TASS.
The Minister of Health Mikhail Murashko reasoned that the volunteers were closely monitored by “a special telemedicine center”, which tracked and monitored the progress of the volunteers. He stated that the drug was perfectly safe for use and the vaccine will continue to be distributed as proposed in the future.
The Lancet writing on September 4, 2020 had raised concern on Sputnik V’s “premature” approval, presenting the arguments of health agencies and experts worldwide, who cautioned that until Phase 3 trials went underway no conclusive statements could be made. The medical journal then went on to specify the extent of the side effects. It recorded that 58% of the volunteers experienced pain on the spot where the vaccine was administered, 50% of them had fever, 42% complained of head-aches, and 24% endured muscle aches.
Facebook Comment
Related News
latest Video
Trending News
- This Week
- This Month
